Popular / View All Posts

Impact of Low-Dose Oral Minocycline (DFD-29) on Skin, Gastrointestinal, and Vaginal Microflora in Healthy Adults

| Featured Articles, Latest News, Rosacea, Women | No Comments
Minocycline ER spares the microbiome: A December JDD highlight In the December issue of JDD we wanted to highlight a randomized, double‑blind, placebo‑controlled microbiome study of DFD‑29 (minocycline hydrochloride extended‑release...
Journal of Drugs in Dermatology JDD Article about The Gastrointestinal Microbiome and Immune Checkpoint Inhibitors: A Review of Human Interventional Studies Among Melanoma Patients

The Gastrointestinal Microbiome and Immune Checkpoint Inhibitors: A Review of Human Interventional Studies Among Melanoma Patients

| Featured Articles, Latest News, Skin Cancer | No Comments
From the Vault: Fecal transplant may revive immunotherapy responses in melanoma We pulled this February 2024 vault article because it’s been a popular read. It’s a focused review of microbiota‑modulating...
Journal of Drugs in Dermatology JDD Article about GLP-1 Receptor Agonists in Hidradenitis Suppurativa: A Novel Therapeutic Approach for Hidradenitis Suppurativa and Its Comorbidities

GLP-1 Receptor Agonists in Hidradenitis Suppurativa: A Novel Therapeutic Approach for Hidradenitis Suppurativa and Its Comorbidities

| Featured Articles, Hidradenitis Suppurativa, Latest News | No Comments
Metabolic drugs for HS? GLP‑1 receptor agonists show promise beyond weight loss If you haven’t yet, dig into this recent JDD article about GLP-1 receptor agnosists and hidradenitis suppurativa. Hidradenitis...

Isotretinoin Does Not Increase the Risk of Inflammatory Bowel Disease: A TriNetX Retrospective Cohort Analysis

| Acne, Featured Articles, Latest News, Medical Derm | No Comments
Isotretinoin and IBD — large real‑world data offer reassurance In one of our recent JDD articles, a retrospective cohort using the TriNetX network compared acne patients exposed to long‑term, low‑dose...